Tudor Investment Corp’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,266
| Closed | -$850K | – | 1748 |
|
|
2025
Q1 | $850K | Buy |
81,266
+38,002
| +88% | +$398K | ﹤0.01% | 1063 |
|
|
2024
Q4 | $1.02M | Sell |
43,264
-7,219
| -14% | -$170K | ﹤0.01% | 1001 |
|
|
2024
Q3 | $1.81M | Buy |
50,483
+3,414
| +7% | +$123K | 0.01% | 793 |
|
|
2024
Q2 | $1.66M | Sell |
47,069
-9,892
| -17% | -$349K | 0.01% | 792 |
|
|
2024
Q1 | $1.62M | Buy |
+56,961
| New | +$1.62M | 0.01% | 743 |
|
|
2023
Q2 | – | Sell |
-61,003
| Closed | -$703K | – | 1635 |
|
|
2023
Q1 | $703K | Buy |
61,003
+746
| +1% | +$8.6K | 0.01% | 1032 |
|
|
2022
Q4 | $698K | Buy |
60,257
+34,057
| +130% | +$395K | 0.01% | 998 |
|
|
2022
Q3 | $333K | Sell |
26,200
-43,863
| -63% | -$557K | 0.01% | 1256 |
|
|
2022
Q2 | $481K | Buy |
70,063
+14,932
| +27% | +$103K | 0.01% | 1089 |
|
|
2022
Q1 | $531K | Buy |
55,131
+16,016
| +41% | +$154K | 0.01% | 1081 |
|
|
2021
Q4 | $465K | Buy |
+39,115
| New | +$465K | 0.01% | 1184 |
|
|
2021
Q3 | – | Sell |
-23,230
| Closed | -$489K | – | 1637 |
|
|
2021
Q2 | $489K | Sell |
23,230
-50,528
| -69% | -$1.06M | 0.01% | 1107 |
|
|
2021
Q1 | $1.15M | Buy |
73,758
+62,992
| +585% | +$978K | 0.02% | 764 |
|
|
2020
Q4 | $226K | Sell |
10,766
-2,708
| -20% | -$56.8K | 0.01% | 1188 |
|
|
2020
Q3 | $272K | Buy |
+13,474
| New | +$272K | 0.01% | 1013 |
|